Insys Therapeutics, Inc. to Present at Morgan Stanley Global Healthcare Conference
September 01 2016 - 07:00AM
Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY)
today announced that Darryl Baker, Chief Financial Officer, and
Santosh Vetticaden, MD, PhD, Senior Vice President and Chief
Medical Officer, will present at the Morgan Stanley Global
Healthcare Conference as follows:
Date: |
|
|
Tuesday, September 13, 2016 |
Time: |
|
|
12:20 p.m. Eastern Daylight Time |
Location: |
|
|
Grand Hyatt, New York |
The presentations will be webcast live at the aforementioned
times as well as archived for 90 days thereafter, via the Company’s
website at www.insysrx.com, under the Investors Section.
About Insys Therapeutics, Inc.
Insys Therapeutics is a specialty pharmaceutical company that
develops and commercializes innovative drugs and novel drug
delivery systems of therapeutic molecules that improve the quality
of life of patients. Using proprietary sublingual spray technology
and capabilities to develop pharmaceutical cannabinoids, Insys is
developing a pipeline of products intending to address unmet
medical needs and the clinical shortcomings of existing commercial
products. Insys currently markets one product, SUBSYS® (fentanyl
sublingual spray) but has received approval for the marketing of
SYNDROSTM (dronabinol oral solution), a proprietary, orally
administered liquid formulation of dronabinol that Insys believes
has distinct advantages over the current formulation of dronabinol
in soft gel capsule. Insys is committed to developing
medications for potentially treating addiction to opioids, opioid
overdose, epilepsy, and other disease areas with high unmet
need.
SUBSYS® and SYNDROSTM are trademarks of Insys Development
Company, Inc., a subsidiary of Insys Therapeutics, Inc.
Investor Contact:
Lisa M. Wilson, President
In-Site Communications, Inc.
Phone: 212-452-2793
Email: lwilson@insitecony.com
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Feb 2024 to Mar 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Mar 2023 to Mar 2024